Trying to sort facts from fiction in the world of stocks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why dont one of you rich guys buy all these cheap shares, I have spent all my wad...! LOL
I hope they don't take me out behind the woodshed...
41 and counting...lol
JCMONEY you know a ton of guys, get them over here....LOL
Good job, you are going to make some coin...GLTY
I hope so cause this is getting old...LOL
Well, then he needs to get them straight if you know what I mean...LOL, Their PPS has tanked and I don't see them doing much about it at this point.
Still holding
If they retained you for another 2 weeks I would say that news is coming within a few days. after all you need "Good" news to help with awareness...GLTA
Added another 6500 today, may add more.
I agree! Good week ahead, maybe great!
Could get wild! we will see what happens this week.
MCVI.017 +008 (88.89%) 5 million Float 9 million OS
Active SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
MCVI.017 +008 (88.89%) 5 million Float 9 million OS
Active SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
UWRL WEEK, its our time..imo
Still holding and adding...Go CCTC
I will be adding as well...Fun week ahead!
I smell shorts on the BBQ this week, IMO don't mess with a female hispanic CEO on a mission. This is not a fwd split, it is a divy and I expect good news to follow. IMO if you are short cover your position by WED to make sure your lender gets their divy or you will notice a major difference for the worse in your brokerage account.
Then I would say ALL short positions would need to be covered ASAP and funds cleared by the 5th in order to avoid the divy. Could be a MOASS this week.
The owner gets the divy, the shorts better cover in time or they will also owe the divy...imo
Shorts would also need to cover I would think by the 2nd or 3rd in order to insure they have "covered" by the 5th and settled...IMO...Not for sure.
UWRL .017+ by EOW
The company needs to release a PR, it would help..LOL
Short Squeeze = PPS Up Up & Away!
Yup! plus maybe a massive short squeeze!
Tell your friends and I will tell mine..LOL
Hold on to your shares!
STOCKEXPLODE.COM has listed UWRL on Watch List for stocks of the week
MOASS in the making, I hope they miss out and cover AFTER the Dividend shares are issued...LOL
Hard to tell, could go much higher with the pending short squeeze that should take place, If they don't cover this week they must come up with 6 more shares for each one shorted...Could be interesting.
I will add some more on Monday, this week should be good.
5 million float….9 million OS impending merger???
Active with SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
These reinstatements are indicative of an impending merger.
Posted by: locksflooring ?Date: Tuesday, January 12, 2010 8:13:01 AM In reply to: None Post #? of 353
Heart health study in Great Lakes Bay Region includes stem cell therapy
By Jill Armentrout | The Saginaw News
January 11, 2010, 10:10AM
Michigan CardioVascular Institute and Covenant HealthCare of Saginaw are enrolling patients in a new stem cell therapy for heart attack patients.
The therapy, Prochymal, is a formulation of adult stem cells that may be able to prevent and treat heart damage after a severe heart attack. The trial will study the therapy’s ability to improve heart function, limit scar formation and preserve functional heart tissue after a patient’s first heart attack. Prochymal is an investigational therapy developed by Osiris Therapeutics Inc.
Dr. Safwan Kassas with MCVI infused the first trial patient with the therapy Dec. 21 at Covenant.
The Phase I trial involved 53 patients, who saw heart function improved and irregular heartbeats reduced after treatment, compared with a placebo group.
A heart attack occurs when blood flow is suddenly and completely blocked. More than half a million Americans will have their first heart attacks this year. American Heart Association data shows that within six years of a recognized heart attack, 18 percent of men and 35 percent of women have a repeat attack. A heart attack can significantly weaken heart muscle, which can lead to chronic heart failure.
This Phase 2 trial will include about 220 patients who come to the emergency room for treatment in the United States and Canada. Those eligible will have had their first heart attacks within the previous seven days. They will receive Prochymal or a placebo along with their present course of treatment.
Participation in the study includes a thorough health evaluation, study medications and laboratory testing. For information about the study and eligibility, call 583-6372.
MCVI.017 +008 (88.89%) 5 million Float 9 million OS
Active SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
Corp reinstatement out of Minnesota, pos reverse merger play....Share structure is a diamond....
MCVI.017 +008 (5 million Float)! (9 million OS)
Active SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
Strong Buy IMO
With or without Wholefoods I suspect something is up and churning here, I am holding to see if anything pans out here.
Yup....I think we are looking at a 50 Mil + merger when all is said and done....GLTY
Still holding strong! Waiting on all the updates from the company.
MCVI .017 5 million float….9 million OS REINSTATEMENT (Merger?)
Active with SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
These reinstatements are indicative of an impending merger.
Posted by: locksflooring ?Date: Tuesday, January 12, 2010 8:13:01 AM In reply to: None Post #? of 353
Heart health study in Great Lakes Bay Region includes stem cell therapy
By Jill Armentrout | The Saginaw News
January 11, 2010, 10:10AM
Michigan CardioVascular Institute and Covenant HealthCare of Saginaw are enrolling patients in a new stem cell therapy for heart attack patients.
The therapy, Prochymal, is a formulation of adult stem cells that may be able to prevent and treat heart damage after a severe heart attack. The trial will study the therapy’s ability to improve heart function, limit scar formation and preserve functional heart tissue after a patient’s first heart attack. Prochymal is an investigational therapy developed by Osiris Therapeutics Inc.
Dr. Safwan Kassas with MCVI infused the first trial patient with the therapy Dec. 21 at Covenant.
The Phase I trial involved 53 patients, who saw heart function improved and irregular heartbeats reduced after treatment, compared with a placebo group.
A heart attack occurs when blood flow is suddenly and completely blocked. More than half a million Americans will have their first heart attacks this year. American Heart Association data shows that within six years of a recognized heart attack, 18 percent of men and 35 percent of women have a repeat attack. A heart attack can significantly weaken heart muscle, which can lead to chronic heart failure.
This Phase 2 trial will include about 220 patients who come to the emergency room for treatment in the United States and Canada. Those eligible will have had their first heart attacks within the previous seven days. They will receive Prochymal or a placebo along with their present course of treatment.
Participation in the study includes a thorough health evaluation, study medications and laboratory testing. For information about the study and eligibility, call 583-6372.
MCVI 5 million float….9 million OS
Active with SOS
http://da.sos.state.mn.us/minnesota/corp_inquiry-entity.asp?:nfiling_number=7J-436&entity_type_id=DC&:Nsession_id=&:Ndocument_number=0&filename=-513508744.txt&pgcurrent=6&:Norder_item_type_id=10&:Ssearch_Parm=medical+cv
These reinstatements are indicative of an impending merger.
Posted by: locksflooring ?Date: Tuesday, January 12, 2010 8:13:01 AM In reply to: None Post #? of 353
Heart health study in Great Lakes Bay Region includes stem cell therapy
By Jill Armentrout | The Saginaw News
January 11, 2010, 10:10AM
Michigan CardioVascular Institute and Covenant HealthCare of Saginaw are enrolling patients in a new stem cell therapy for heart attack patients.
The therapy, Prochymal, is a formulation of adult stem cells that may be able to prevent and treat heart damage after a severe heart attack. The trial will study the therapy’s ability to improve heart function, limit scar formation and preserve functional heart tissue after a patient’s first heart attack. Prochymal is an investigational therapy developed by Osiris Therapeutics Inc.
Dr. Safwan Kassas with MCVI infused the first trial patient with the therapy Dec. 21 at Covenant.
The Phase I trial involved 53 patients, who saw heart function improved and irregular heartbeats reduced after treatment, compared with a placebo group.
A heart attack occurs when blood flow is suddenly and completely blocked. More than half a million Americans will have their first heart attacks this year. American Heart Association data shows that within six years of a recognized heart attack, 18 percent of men and 35 percent of women have a repeat attack. A heart attack can significantly weaken heart muscle, which can lead to chronic heart failure.
This Phase 2 trial will include about 220 patients who come to the emergency room for treatment in the United States and Canada. Those eligible will have had their first heart attacks within the previous seven days. They will receive Prochymal or a placebo along with their present course of treatment.
Participation in the study includes a thorough health evaluation, study medications and laboratory testing. For information about the study and eligibility, call 583-6372.
GDVI* This line from their most recent S-8 really says all that needs to be said in regards to the potential to run here:
"We are authorized to issue 75,000,000 shares of common stock, and we have no other classes of shares. Currently we have 42,400,000 shares outstanding. We have no options or warrants outstanding."
* Then, take a look at their most recent 10-Q. Their operating expense per quarter is just over $6,000. That looks like just paying the accountant to prepare and file with the SEC. There is less than 80K in liabilities. This is an amazingly clean SEC reporting shell! Reading the 10-Q, it is obvious their business is done in my opinion and what you have left is a shell that a multi-million dollar a year company will merge into.
* Then there's this : GVDI big find! Looks like something may be in the works with Whole Foods! GVDI website changed - http://www.goldenvalleydevelopment.com
Straight from their last 10K/A, www.goldenvalleydevelopment.com is their website. Something big is up here! This tells you why the buying pressure has been happening.
* BTW, Whole Foods Market Inc. (WFMI) currently trading @ $ 35.49 USD (nasdaq)
http://www.nasdaq.com/asp/summaryquote.a...
* The director of GDVI, Arthur Davis is also the VP/Owner of Adavco Inc.
Here is Mr Davis profile link
http://people.forbes.com/profile/h-arthu...
GDVI business profile from the 10-K of 2008
'http://biz.yahoo.com/e/090325/gvdi.ob10-...
Mr Arthur Davis forte is whole foods/produce brokering.....Whole Foods is in this market.
Pure speculation on my part but it maybe that Whole Foods is interested in aquiring Mr Davis' expertise and holdings....
* Also, just want to add...The more I think about this the more it makes sense. My theory/speculation that is! If WholeFoods aquires Mr Davis & GVDI and the quality, whole foods brokering exchange expertise + a clean shell to setup their very own Whole Foods Produce brokering exchange then Whole Foods will be able to control 3 very important things:
1. Quality
2. Where the produce is purchased from (True Organic produce/small farmers that complies with Whole Foods Organic Food Produce quality definitions and policies) and lastly
3. Better control of the cost = better consumer pricing = better competition.
* Now look what happened yesterday : volume 26 feb. 2010 = 762,969
562,803 traded @ ask / 199,181 traded @ bid / 985 in between
short volume 551,565
http://ih.advfn.com/p.php?pid=trades&cb=...
http://regsho.finra.org/FORFshvol2010022...
This is going to be a huge short squeeze. The MM's have no shares. They were shorting this at .01 also. They have to cover. This could go to .05 in a day.